Hierarchical accumulation of RyR post-translational modifications drives disease progression in dystrophic cardiomyopathy by Kyrychenko, S. et al.
 Hierarchical accumulation of RyR post-translational modifications drives disease 
progression in dystrophic cardiomyopathy.  
Sergii Kyrychenko1*, Eva Poláková1*#, Chifei Kang1, Krisztina Pocsai1, Nina D. Ullrich2, Ernst 
Niggli2 and Natalia Shirokova1. 
From the Department of Pharmacology and Physiology1, UMDNJ– New Jersey Medical School, 
Newark 07103, NJ, USA and the Department of Physiology2, University of Bern, CH-3012 Bern, 
Switzerland.  
 
*Sergii Kyrychenko and Eva Poláková contributed equally to this work. 
 #Eva Poláková current address: Department of Pharmacology & Systems Therapeutics, Mount 
Sinai School of Medicine, New York 10029, NY, USA  
 
 
Running title: cellular phenotype of cardiac dystrophy 
Key words: Dystrophic cardiomyopathy, excitation-contraction coupling, ryanodine receptor, 
Ca2+ signals  
 
Total word count: 6320 
 
Address correspondence to: N. Shirokova, Department of Pharmacology and Physiology, 
University of Medicine and Dentistry – UMDNJ, 185 S. Orange Ave., Newark 07103, NJ, USA. 
E-mail: nshiroko@umdnj.edu. Ph: (973) 972 8877. Fax: (973) 972 7950. 
0DQXVFULSW
s
o
u
r
c
e
:
 
ht
tp
s:
//
do
i.
or
g/
10
.7
89
2/
bo
ri
s.
45
84
1 
| 
do
wn
lo
ad
ed
: 
13
.3
.2
01
7
Cellular phenotype of cardiac dystrophy (CVR-2012-983R2) 
2  
Aims: Duchenne muscular dystrophy (DMD) is a muscle disease with serious cardiac 
complications. Changes in Ca2+ homeostasis and oxidative stress were recently associated with 
cardiac deterioration, but the cellular pathophysiological mechanisms remain elusive. We 
investigated whether the activity of ryanodine receptor (RyR) Ca2+ release channels is affected, 
whether changes in function are cause or consequence and which post-translational 
modifications drive disease progression. 
Methods and Results: Electrophysiological, imaging and biochemical techniques were used to 
study RyRs in cardiomyocytes from mdx mice, an animal model of DMD. Young mdx mice show 
no changes in cardiac performance, but do so after ~8 months. Nevertheless, myocytes from 
mdx pups exhibited exaggerated Ca2+ responses   to   mechanical   stress   and   “hypersensitive”  
excitation-contraction coupling, hallmarks of increased RyR Ca2+ sensitivity. Both were 
normalized by antioxidants, inhibitors of NAD(P)H oxidase and CaMKII, but not by NO- 
synthases and PKA antagonists. SR Ca2+ load and leak were unchanged in young mdx mice. 
However, by the age of 4-5 months and in senescence, leak was increased and load was 
reduced, indicating disease progression. By this age, all pharmacological interventions listed 
above normalized Ca2+ signals and corrected changes in ECC, Ca2+ load and leak.  
Conclusions: Our findings suggest that increased RyR Ca2+ sensitivity precedes and 
presumably drives the progression of dystrophic cardiomyopathy, with oxidative stress initiating 
its development. RyR oxidation followed by phosphorylation, first by CaMKII and later by PKA, 
synergistically contributes to cardiac deterioration. 
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1. Introduction. 
Cytoskeletal remodeling often accompanies cardiac hypertrophy and failure1. 
Dystrophinopathies represent a unique group of diseases in which the cytoskeletal disarray is 
not only a consequence but also the cause of the disease. They result from mutations in the 
dystrophin gene2. Duchenne muscular dystrophy (DMD) is among the most severe forms of 
dystrophy. Cardiac manifestations of the disease are present in the majority of adolescent boys 
with DMD. About 20% of the patients suffer from ventricular dysfunctions and arrhythmias that 
ultimately lead to heart failure or sudden cardiac death3. The most commonly used animal 
model of DMD is the mdx mouse, which lacks dystrophin. Mdx mice develop dilated 
cardiomyopathy over an eight-month period4,5. By that age they also show electrocardiographic 
and MRI abnormalities and develop sustained ventricular tachycardia when challenged with 
isoproterenol6. 
 The cellular pathology of the failing heart often shows impaired intracellular Ca2+ 
homeostasis, including abnormal excitation-contraction (EC) coupling7. It is well described that 
at different stages of dystrophic cardiomyopathy its cellular phenotype exhibits augmented 
intracellular Ca2+ responses (i.e. a burst of Ca2+ sparks and waves) to mechanical stress8-10, 
hypersensitive EC-coupling 11, increased Ca2+ leak from the sarcoplasmic reticulum (SR) and 
reduced SR Ca2+ load6. These features clearly point to modifications in intracellular Ca2+ cycling 
and suggest elevated activity of Ca2+-induced Ca2+ release (CICR) from the SR via ryanodine 
receptor (RyR). As underlying causes, several and probably not mutually exclusive mechanisms 
of RyRs sensitization have been considered. They include oxidative9 and nitrosative6 post-
translational modifications of RyRs as well as their phosphorylation by PKA12. However, a 
causal links between these modifications and alterations of RyR function, development of 
cellular abnormalities and progression of dystrophic cardiomyopathy have not yet been 
established clearly.  
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 The aim of this study was to define the interactions among several cellular 
pathomechanisms that converge to a common end-point – they ultimately all sensitize or even 
hypersensitize the CICR machinery, in particular the RyRs. In addition, we wanted to determine 
whether RyR hypersensitivity to Ca2+ precedes and therefore possibly underlies the progression 
of this disease. We found that gradually developing and additive modifications of RyRs provoke 
the degradation of cardiomyocyte function that may ultimately result in cardiac failure in 
muscular dystrophy. 
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2. Methods 
For additional information on methods see Supplementary material online.  
 
2.1. Cell isolation 
All experiments conformed with the NIH Guide for the Care and Use of Laboratory Animals 
published by the US National Institute of Health (NIH publication, 8th Edition, 2011) and were 
approved by the Institutional Animal Care and Use Committee of the New Jersey Medical 
School, USA and by the State Veterinary Office of Bern, Switzerland. C57BL10 mice (wild-type, 
WT) and dystrophin-deficient mdx (C57BL/10ScSn-mdx) mice at the age of 1 (young), 3-4 
(adult) and 12-15 months (senescent) were used in this study. Animals were purchased from 
the Jackson Laboratory. Ventricular myocytes were enzymatically isolated as previously 
described13. Briefly, mice were heparinized (5,000 U/kg), anesthetized with sodium 
pentobarbital (100 mg/kg), and checked to ensure absence of movement, flexor  and pedal 
reflexes. Hearts were then quickly removed, mounted on a Langendorff apparatus and perfused 
with a solution containing collagenase and protease. Ventricles were cut into small pieces from 
which cells dissociated with time. Myocytes were used for experiments within 5 hours after 
isolation.  
 
2.2. Cellular experiments 
Changes in cytoplasmic [Ca2+] and production of reactive oxygen species (ROS) were 
monitored with fluorescent indicators fluo-3   AM   (5   μM)   and   5-(and-6)-chloromethyl-2’,7’-
dichlorodihydrofluorescein diacetate (CM-H2DCFD,   20  μM),   respectively   and  a   laser-scanning 
confocal microscope (Bio-Rad, Radiance 2000) in XY-scan mode at the rate of 0.5 Hz. Dyes 
were excited with the 488 nm line of an Argon laser. The emitted light was collected above 500 
nm. SR Ca2+ leak was estimated as described in14. Cells were paced at 1 Hz in external control 
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solution to obtain steady-state levels of SR Ca2+ load, and starting from the last five beats, 
[Ca2+]i was recorded in the line-scan mode (500 lines/s). After pacing, external solution was 
rapidly switched to Na+ and Ca2+-free solution for 15 s to stop Ca2+ influx and to inhibit Ca2+ 
removal via the NCX and thus, to avoid Ca2+ overload or Ca2+ unloading of the cells. Addition of 
tetracaine (1 mM, 15 s) eliminated RyR-mediated diastolic Ca2+ leak, leading to a rapid 
decrease in [Ca2+]i proportionally to the leak. The peak of the caffeine-induced Ca2+ transient 
measured after tetracaine washout (10 mM caffeine, 2 s) was used to estimate SR load. 
Membrane currents were recorded using the whole cell patch-clamp technique with an 
Axopatch 200B amplifier (Axon Instruments). Cells were voltage clamped using low-resistance 
(1.5–3  MΩ)  borosilicate  glass  micropipettes  filled  with  pipette  solution  which  contained    (in  mL):  
120 CsAsp, 8 NaCl, 20 tetraethylammonium (TEA)-Cl, 5.5 MgCl2, 4 KATP, 5 HEPES, and 0.1 
K5-fluo-3. pH was adjusted to 7.2 with CsOH and osmolarity was 305 mOsm. All experiments 
were carried out at room temperature, which may represent an experimental limitation of our 
studies.  
 
2.3. Phosphorylation and oxidation of RyRs 
Phosphorylation status of RyRs at Ser-2808 (PKA) and Ser-2814 (CaMKII) was assessed with 
antibodies purchased from Badrilla (UK) and CaMKII expression was evaluated with antibodies 
donated by Dr. M.E. Anderson (University of Iowa) using standard procedures15. Briefly, mouse 
ventricular tissue was collected and sonicated in the radio-immunoprecipitation assay (RIPA) 
lysis buffer.  40  μg  of  protein  lysate  per  sample  was  denatured  in  4X  SDS-PAGE sample loading 
buffer. Proteins were separated by electrophoresis in 4% (for RyR2) and 10% (for CaMKII) 
respectively SDS-polyacrylamide gel, transferred to nitrocellulose membrane (Bio-Rad, CA) at 
15V for 16-18 h at 40C (for RyR2) and at 90V for 15 h at 40C (for CaMKII), blocked with 1% BSA 
in TRIS buffered saline and Tween (TBS: 20mM TRIS-HCl, 200mM NaCl, 0.6% tween 20, pH 
7.5) for 1 hour and probed for proteins of interest.  
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 The content of free thiols was determined using a monobromobimane (mBB, 
Calbiochem, USA) assay16. Isolated cardiomyocytes were permeabilized and incubated with 1 
mM of mBB for 1 hour in a dark room. The proteins were separated in 4-15% TGX SDS-gels 
(Bio-Rad, CA) and imaged with UV excitation (360 nm). Total RyR2 was determined from 
Coomassie blue staining of gels run in parallel and confirmed by western blotting with anti-
RYR2 (Thermo Scientific, MA) and Mass Spectrometry at UMDNJ core facility. 
 
2.4. Statistics 
Results are shown as mean ± standard error (SEM). All data sets contain results from a 
minimum of three mice (n on the figures indicates the number of cells studied with imaging and 
electrophysiological techniques or the number of tissue samples in biochemical experiments). 
Statistical   significance  was  evaluated   by  Student’s   t-test. A P-value of <0.05 was considered 
significant.
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3. Results 
3.1. RyRs are already hypersensitive to activation by Ca2+ in myocytes from young mdx 
mice 
At the age of one month dystrophic mice do not exhibit any signs of cardiac disease. However, 
74% of apparently normal dystrophic cardiomyocytes exhibited exaggerated intracellular Ca2+ 
signals (Ca2+ waves and sparks) in response to a mechanical challenge applied as mild hypo-
osmotic shock at rest. In contrast, intracellular Ca2+ transients in WT cells were minimal and 
detected only in 20% of myocytes (Figure 1A). Since the extent of Ca2+ influx is only slightly 
larger in mdx myocytes9,17, this observation was taken as a strong indication of increased Ca2+ 
sensitivity of RyRs in young dystrophic hearts. 
 In order to obtain more detailed insight into RyR function, we measured Ca2+ currents 
(ICa), corresponding Ca2+ transients and determined the gain of EC-coupling in patch-clamped 
cells. EC-gain reflects the efficiency of signal transduction between L-type Ca2+ channels and 
RyRs. The gain is calculated as the ratio of Ca2+ transient amplitude to the peak of 
corresponding ICa. When cells were superfused with a normal experimental solution, containing 
1.8 mM Ca2+, we found no significant difference in the amplitudes of ICa, Ca2+ transients and 
values of EC-coupling gain between the two groups of cells within a range of test voltages (-25 
to +50 mV). This observation was in agreement with our previous findings in myocytes from 
more mature animals11. Then we repeated the analysis of Ca2+ transients and ICa at the lowest 
test voltage (-25 mV), but under conditions that challenge the fidelity of EC-coupling 
mechanisms - reduced Ca2+ concentration in the superfusion solution (0.5 mM instead of 1.8 
mM11,18. As a result, the ICa and Ca2+ transient amplitudes were significantly decreased in all 
cardiomyocytes. However, the corresponding reduction in the amplitude in cytosolic Ca2+ 
transient was significantly less in mdx cells compared to WT, while the amplitude of ICa was 
affected to the same extent (Figure 1B, middle panes). This corresponds to a significantly 
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smaller reduction in EC-coupling gain in dystrophic cells (Figure 1B, right panels). Thus, in 
contrast to young WT myocytes, SR Ca2+ release in mdx cells exhibited a surprising resistance 
to the reduction in ICa trigger, revealing a hypersensitivity in EC-coupling that is an additional 
indication of an increased sensitivity of RyRs to Ca2+. 
 An abnormal Ca2+ sensitivity of the RyRs could manifest itself as an elevated SR Ca2+ 
leak, resulting in a decreased Ca2+ content of the SR, reduced SR Ca2+ release and impaired 
cellular contractility. Such changes were previously observed in 3-4 month old mdx myocytes 
and were attributed to hyper-phosphorylation of RyRs by PKA19. We compared the transient 
Ca2+ leak from the SR as well as the resting SR Ca2+ load using a method developed in14. The 
SR of intact cardiomyocytes was loaded with Ca2+ by a train of field stimulations. Subsequently, 
the SR Ca2+ leak was estimated from the decrease in resting [Ca2+]i following addition of the 
RyR blocker tetracaine. The peak of a caffeine-induced Ca2+ transient after tetracaine washout 
was used to estimate the SR Ca2+ load. No statistically significant increase in the transient SR 
Ca2+ leak was observed in myocytes from young mice, suggesting that the detection of such 
changes requires more severe modifications in RyRs functions (see below). The somewhat 
higher SR Ca2+ content in mdx myocytes may result from the slightly elevated trans-
sarcolemmal Ca2+ influx in these cells9,17,20. 
 
3.2. Hypersensitivity of RyRs is driven by oxidation in young mdx myocytes  
There is a number of post-translational modifications that may contribute to the increased 
sensitivity of RyR activation by Ca2+. Oxidation, nitrosation and phosphorylation are among 
them. Oxidative modification of RyRs was one of the first proposed mechanisms contributing to 
an impaired Ca2+ homeostasis of dystrophic cardiomyocytes9,21. Moreover, an increased activity 
of plasmalemmal NAD(P)H oxidase (NOX) was identified to be a major source of oxidative 
stress in dystrophic cardiomyopathy9,10,21. Here we tested whether oxidative stress modifies RyR 
functions already in very early stages of the disease. Four groups of experiments were 
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performed: we 1) compared the extent of ROS production in WT and mdx cardiomyocytes with 
confocal microscopy and CM-H2DCFDA; 2) assessed the oxidation and phosphorylation status 
of RyRs using mBB assays and phospho-specific antibodies against RyR PKA and CaMKII sites 
Ser-2808 and Ser-2814; 3) evaluated the oxidative status of CaMKII with antiserum against 
oxidized Met281/282 residues; and 4) tested whether scavengers of ROS, inhibitors of NOX, 
CaMKII, PKA and various isoforms of nitric oxide synthase (eNOS, nNOS and iNOS) 
“normalize”   hypersensitive   Ca2+ responses to osmotic shock and EC-coupling in dystrophic 
myocytes.  
 To assess oxidative stress, myocytes isolated from WT and mdx mice were identically 
loaded with CM-H2DCFDA. CM-H2DCFDA is hydrolyzed to DCFH in the cell, and DCFH is 
oxidized to form the highly fluorescent DCF compound in the presence of an appropriate 
oxidant. It should be noted that, as many other ROS indicators, DCF is not exclusively selective 
to detect ROS, but also some reactive nitrogen species (RNS). DCF-related fluorescence was 
followed for ~3 min under resting conditions (Figure 2A). The slope of the averaged DCF signal  
largely reflects the rate of cellular ROS production. It was significantly greater in mdx cells. 
Another way to assess the redox state of the cytosol is to normalize resting DCF fluorescence 
(F0) to the signal after addition of 10 mM H2O2 (Fmax) The relative increase of fluorescence after 
addition of H2O2 was significantly smaller in mdx myocytes, also indicating an increased resting 
ROS/RNS level in dystrophic hearts of young animals. Purified cardiac RyR tetramer contains 
multiple free cysteines22 which can be readily oxidized. The content of free thiols in RyRs was 
determined with the mBB technique. Relative content of free thiols in RyR was ~70% greater in 
WT, suggesting that oxidative stress in dystrophic cells resulted in oxidation of RyRs (Figure 
2B). 
 RyRs are also predisposed to phosphorylation by both CaMKII and PKA. Moreover, 
CaMKII itself is susceptible to oxidative activation23. Based on our data, the enzyme is expected 
to be more actively involved in mdx cardiomyocytes, as the amount of oxidized enzyme 
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increased about 2-fold in dystrophic cells (Figure 2C). We assessed the phosphorylation status 
of RyRs with phospho-specific antibodies against Ser-2814 (putative phosphorylation site for 
CaMKII) and Ser-2808 (proposed site for PKA phosphorylation). These experiments indicate 
that CaMKII-, but not PKA-mediated phosphorylation, also contribute to the early cellular 
dysfunctions in dystrophic cardiomyopathy (Figure 2D). 
 To further evaluate the contribution of each particular post-translational RyR 
modification, a set of functional studies with various pharmacological tools was carried out. 
Figure 2E illustrates that the reducing agent 2-mercaptopropionyl glycine (MPG, 1 mM), 
inhibitors of NOX (apocynin, 0.5 mM and diphenylene iodonium (DPI), 10 µM) and CaMKII (K-
93, 5 µM and Autoctamide-2 Related Inhibitory Peptide (AIP), 2.5 µM) reversibly inhibited 
intracellular Ca2+ responses to osmotic shock and normalized EC-coupling in mdx cells. In 
contrast, various PKA inhibitors (H89, 5 µM, KT5720, 2 µM and PKA inhibitory peptide (PKI), 5 
µM) as well as inhibitors of nNOS, eNOS and iNOS (S-methyl-L-Thiocitrulline (SMLT), 10 µM 
and 1400W, 100 nM, respectively) had no significant effect on the intracellular Ca2+ signals in 
mdx myocytes from young animals (see Table 1S for details). Please note that after testing a 
broad range of inhibitors of PKA and CaMKII in the experiments with osmotic shock, we used 
only the more specific inhibitory peptides of kinases (AIP and PKI) in subsequent work. Right 
panel in Figure 2D shows  that  “hypersensitive”  gain  of  EC-coupling in dystrophic cells was also 
normalized by reducing factors and inhibitors of NOX and CaMKII but was not affected by 
inhibitors of PKA or NOS. These results are in agreement with biochemical studies by us and 
others6,19 that did not reveal changes in PKA-phosphorylation or nitrosative status of RyRs in 
very young mdx hearts. Taken together, the findings presented so far are consistent with the 
hypothesis that oxidative stress due to an increased production of ROS by NOX drives the 
cellular pathology of cardiac dystrophy at very early stages of the disease.  
  
3.3. The progression of cellular pathology in cardiac dystrophy 
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Data presented above suggest that cellular abnormalities in isolated dystrophic cardiomyocytes 
clearly precede the first clinical signs of cardiomyopathy4,5. Here we followed up on the 
progression of the cellular phenotype of the disease to the age where heart dysfunction 
becomes prominent. Ventricular myocytes were isolated from 3-4 and 12-15 month old animals. 
Similar to the experiments shown above, intracellular Ca2+ responses to mild osmotic shock, 
EC-coupling, SR Ca2+ leak and load were examined. Data are summarized in Figure 3, which 
also includes some results from one month old mice adapted from Figure 1 for comparison. 
With the progression of the disease, more mdx cardiomyocytes exhibited excessive intracellular 
Ca2+ responses to osmotic shock (74%, 90% and 95% for the three age groups studied, 
respectively). EC-coupling became extremely hypersensitive at the age of 3-4 month (just 
before the clinical onset of the disease) but sensitivity remained relatively high in the senescent 
animals. Contrary to cells from young mice, the transient SR Ca2+ leak significantly increased in 
mdx cells isolated from 3-4 month old animals. This was associated with a tendency towards 
reduced SR Ca2+ content. However, a significant decrease in the SR Ca2+ load was only 
recorded in very old animals that had already developed cardiac myopathy. This decrease is at 
least partly responsible for a reduced resistance of the EC-coupling gain to challenges when 
compared to younger animals (i.e. reducing [Ca2+] in the external solution and applying a small 
test depolarization, Figure 3 B).  
 We also carried out experiments similar to those illustrated in Figure 2. It seems that by 
the age of 3-4 months (just before the appearance of clinical signs of cardiac dystrophy) several 
post-translational modifications additively enhance RyR function resulting in increased SR Ca2+ 
leak, reduced SR Ca2+ content and consequently impaired force production by the individual 
myocytes. In cells from mdx mice older than 3 months activation of NOS and PKA also seems 
to contribute to the hypersensitivity, possibly further aggravating the disease at later stages. A 
variety of pharmacological tools supports this conclusion as they not only normalized 
intracellular Ca2+ responses during mechanical stress and EC-coupling in older animals (Figure 
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4 A and B) but also significantly reduced intracellular Ca2+ leak in senescent mice (Figure 4 C).
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4. Discussion 
Most cardiac diseases are accompanied by substantial remodeling of the heart tissue, also on 
cellular and molecular level24. Depending on the cause of the illness and the particular 
pathophysiology, various adaptive remodeling mechanisms can initially compensate for the 
functional impairments. Unfortunately, some of these initially beneficial processes can become 
maladaptive with time and during progression of the illness, finally aggravating rather than 
improving the cardiac condition. This interplay between 1) defects causing a cardiac disease 
and 2) the remodeling mechanisms that try to maintain function leads to a very complex 
situation. This complexity makes it extremely challenging to unravel the causal disease 
mechanisms and to comprehend the evolution of the disease. However, such an understanding 
would greatly facilitate the development of new therapies and the identification of new drug 
targets. 
 One possible strategy to gain insight into the interplay between causal and adaptive 
alterations of cardiac muscle is to follow the disease progression over longer periods of time. 
This approach is based on the rationale that causal changes can presumably be identified from 
the beginning of the disease, even before the pathology becomes manifest, while adaptive and 
maladaptive processes will develop at later stages only. 
 Based on this reasoning we carried out the present study, examining disease 
progression in dystrophic cardiomyopathy. Because of their slowly developing cardiac 
phenotype mdx mice are a useful model for studies of the progression of DMD that can help to 
identify the cellular sequence of events leading from the genetic defect (lack of functional 
dystrophin) to the onset of cardiac disease. Hearts of 1-2 month old mdx mice seem to have 
normal morphology, left ventricular function and echocardiograms. First signs of cardiac 
disease, such as reduced left ventricular filling, ejection fraction and ejection rate, are seen only 
in 3 month old animals. These changes are more prominent and can be detected earlier in the 
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right ventricle. By 8 months of age, hearts from mdx mice are dilated, hypertrophied, somewhat 
fibrotic and poorly contracting4,5,25. Ventricular cardiomyocytes isolated from senescent but not 
young mdx animals also show signs of dilated cardiomyopathy. The diameter of mdx myocytes 
from old animals is significantly smaller, and their length is significantly greater than of WT cells 
(in  μm:  22.2  ±  0.6  and  127.8  ±  2.4  (n=57)  vs  24.7  ±  0.77  and  116.1  ±  2.5  (n=65)),  although  cell  
capacitance is not changed (in pF: 239.0 ± 21.2 (n=32) vs  244.5 ± 20.6 (n=32) in mdx and WT 
cells, respectively). Tropnonin I was found to be degraded in dystrophic hearts21. In addition, 
measurements in dystrophic mdx papillary muscles revealed that the myofibrillar Ca2+ sensitivity 
is reduced, a finding which contributes to the weak force, in addition to the smaller Ca2+ 
transients26. Additionally, electrocardiographic (ECG) deviations such as diminished R- and S-
wave amplitudes gradually become apparent in mdx mice. By the age of 6 months shortening of 
the PR interval and polymorphic R-waves suggest disturbances in the cardiac conduction 
system27,28.  
 While in the mdx mouse cardiomyopathy only becomes apparent in adulthood, the 
dystrophin protein is absent throughout the lifetime of the animal. Thus, functional 
consequences of the lack of dystrophin, such as stress sensitivity, would be expected to be 
present even in very young and apparently healthy mice. For our study, we focussed on the 
presently prevailing hypothesis to explain the damages caused by the lack of this protein, which 
links   cytoskeletal   proteins   with   the   cell   environment:   the   “Ca2+ hypothesis of muscular 
dystrophy”29. This hypothesis proposes that the membrane fragility resulting from the lack of 
dystrophin leads to extra influx of Ca2+ via micro-ruptures and/or stretch activated channels, and 
that these Ca2+ signals are subsequently amplified by CICR and ultimately lead to activation of 
Ca2+ activated proteases, to mitochondrial damage and apoptotic or necrotic cell death. This 
hypothesis has recently been elaborated to contain another aggravating culprit, excessive 
oxidative stress. 
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 Our results obtained in cardiomyocytes isolated from young animals now suggest that 
the oxidative stress is possibly among the very initial problems dystrophic myocytes encounter. 
In these cells ROS production was already abnormally high. Furthermore, ROS scavengers and 
inhibitors of NAD(P)H oxidase could prevent most of the acute Ca2+ signaling alterations, 
suggesting NOX as the primary source of this oxidative stress. Why and how NOX becomes 
abnormally activated in dystrophic cells is not entirely clear and several possibilities exist. For 
example, NOX over-expression has been reported in dystrophic muscle21,30. Activation of NOX 
could occur indirectly after Ca2+ influx, via phosphorylation by Ca2+ sensitive PKC31-33. PKC 
could also become activated via Angiotensin II receptor signaling, which seems to be activated 
by stretch, even in the absence of an agonist34. An activation of NOX by stretch exerted via the 
intracellular tubulin network has also been suggested10. 
 NOX/ROS mediated signaling has a significant downstream impact on Ca2+ signaling 
proteins, and presumably on many other proteins important for cell function. RyRs are not 
exquisitely susceptible to oxidative modulation. ROS can also turn on CaMKII in a Ca2+ 
independent way23. This leads to further RyR sensitization by CaMKII dependent 
phosphorylation, as observed here with antibodies and with pharmacological CaMKII inhibitors. 
Taken together, these mechanisms explain the susceptibility of dystrophic cardiomyocytes and 
their Ca2+ signaling system to stress at the very early subclinical phases of the disease.  
 Our studies further suggest that later during the progression of dystrophic 
cardiomyopathy, but before heart failure is observed, nitrosation and PKA-dependent 
phosphorylation contribute to the increased sensitivity of RyRs to Ca2+, in agreement with 
recently published data6,19. At this stage of the disease mdx mice as well as DMD patients often 
exhibit electrocardiographic abnormalities, such as premature ventricular beats. Moreover, 
during physical or emotional stress CPVTs also have been reported in boys with DMDs35. It is 
possible  that  under  these  conditions  additional  β-adrenergic input may lead to SERCA and ICa 
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stimulation, followed by phosphorylation of the RyRs, culminating in a high arrhythmogenic 
potential due to overloaded SR and hypersensitive RyRs 19. 
 Finally, our data indicate that at the terminal stages of cardiac dystrophy, several post-
translational modifications together hypersensitize RyR to an extent where SR Ca2+ leak 
dramatically increases This may subsequently contribute to cytosolic and mitochondrial Ca2+ 
overload9,17, activation of necrotic and apoptotic processes and loss of functional myocytes. The 
latter step usually precedes the development of cardiac fibrosis and reduction in heart 
contractility4. In parallel, enhanced and uncompensated SR Ca2+ leak results in a reduction in 
SR Ca2+ load, which will in turn reduce the amplitude of beat to beat intracellular Ca2+ transients, 
thus resulting in reduced force production by the surviving cardiomyocytes. These two cellular 
processes could eventually impede cardiac contractility leading to cardiac failure. 
 
5. Conclusions.  
The present study revealed the gradual time-dependent unfolding of prominent disease 
pathomechanisms in dystrophic hearts. Our major conclusion is that overall oxidative stress 
may be more important as one of the early steps of an initial cellular injury than previously 
thought.  We   suggest   that   the   “Ca2+ hypothesis”   of   cardiac   dystrophy   should   be   significantly 
modified as it was previously implemented for skeletal muscle disease36. Obviously, this view 
should also be considered when developing new therapies for muscular dystrophy. One can 
speculate that therapies could even benefit from a combined approach, where oxidative stress 
and RyR hypersensitivity would be targeted simultaneously. 
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Figure Legends 
Figure 1 Intracellular calcium homeostasis in cardiomyocytes from 1 month old mice (A) 
Intracellular Ca2+ responses to mild hypo-osmotic shock in WT and mdx cells. Left panels are 
XY images of cardiac myocytes after returning to isotonic solution and line-scan representations 
of series of images acquired from the cells on the left upon application of an osmotic challenge. 
Averaged fluorescence was determined within each cell and converted to a two-dimensional X,t 
image (as in32). Bars under the line-scans depict the protocol of extracellular solution changes. 
Right panel represents pooled data of mean values of normalized fluorescence during 60 sec 
after the osmotic shock. The averaged response to the osmotic shock was extremely small in 
WT cells compared to mdx. (B) Left panels show representative traces of Ca2+ currents, line-
scan images of Ca2+-related fluorescence and normalized cytosolic transients elicited by a 400 
ms test pulse to -25 mV in WT and mdx cells superfused with either 1.8 mM or 0.5 mM Ca2+. 
Line plot on the top represents the voltage protocol used for the experiments. Right panel shows 
the statistical comparison of EC-coupling gain in 0.5 mM Ca2+ in WT and mdx cells. For each 
group, data were normalized to the value of the gain obtained in 1.8 mM Ca2+. SR Ca2+ release 
was much more resistant to the reduction in ICa trigger in mdx myocytes. (C) Left panels 
illustrate intracellular Ca2+ signals during the protocol designed to estimate SR Ca2+ leak (as 
in14): line-scan images of fluo-3 fluorescence and normalized cytosolic transients. Bars on the 
bottom depict the protocol of extracellular solution changes. Averaged values of estimated SR 
Ca2+ leak and SR Ca2+ load in WT and mdx cells are shown at the right. The SR Ca2+ leak was 
determined as a reduction in the resting fluo-3 fluorescence following tetracaine application, 
expressed as a % of SR Ca2+ content estimated from the amplitude of the caffeine-induced SR 
Ca2+ transient. There was no significant difference in the values obtained in WT and mdx cells. 
See Table 1S for details. 
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Figure 2 Post-translational modifications of RyRs in cells from 1 month old mice (A) 
Representative images of DCF fluorescence in WT and mdx myocytes under resting conditions 
and after application of 10 mM H2O2. Graph at the bottom left illustrates changes in the 
averaged DCF signals. Bar graphs compare the rate of DCF oxidation (slope) at rest and 
normalized increases in DCF signals after application of H2O2 in WT and mdx cells . The values 
were 0.027±0.004 and 0.039±0.003 for the slope and 5.36±0.57 and 7.46±0.64 for F0/Fmax in 
mdx and WT cells respectively. Both groups of measurements indicate higher ROS production 
in mdx cells. (B) Representative Coomassie-stained gel and mBB fluorescence intensity blot in 
samples from WT and mdx hearts. Bar plot shows averaged data on free thiol content in RyRs 
from WT myocytes normalized to the corresponding value in mdx cells. Level of free thiols is 
significantly greater in WT hearts. (C) Immunoblots and summary of oxidized CaMKII. Band 
intensities recorded from mdx samples were normalized per GAPDH signals and expressed as 
a percentage of increase compared to values obtained in WT samples. Level of oxidized 
CaMKII are almost 2 fold higher in mdx hearts. (D) Immunoblot and summary of phosphorylated 
RyR. Whereas normalized intensity of CaMKII dependent immunoreactivity increased ~3 fold in 
dystrophic tissue, the value did not change significantly for the PKA site. Numbers of samples 
studied are indicated on the bars. (E) Reduction in oxidative stress and CaMKII inhibition 
suppress exaggerated intracellular Ca2+ responses to osmotic shock (left panel) and prevent 
hypersensitivity of EC-coupling (right panel). In the experiments with osmotic shock, individual 
intracellular Ca2+ responses were averaged within each experimental group (e.g. each 
pharmacological intervention applied) and normalized to the averaged response under control 
conditions (no drug applied). In the EC-coupling gain experiments, averaged data within each 
experimental group were also normalized to the values obtained in control (no drug applied) 
conditions. Details are in Table 1S. 
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Figure 3 Gradual deterioration of intracellular Ca2+ homeostasis during the development of 
cardiac dystrophy. Intracellular Ca2+ responses to osmotic shock (A), gain of EC-coupling (B), 
intracellular Ca2+ leak (C) and SR Ca2+ content (D) in WT and mdx cardiomyocytes isolated from 
1, 3-4 and 12-15 month old mice. Please note the gradually increased SR Ca2+ leak and 
decreased SR Ca2+ load in mdx cardiomyocytes from older mice. The corresponding values are 
listed in Table 2S.  
 
Figure 4 Reduction in oxidative/nitrosative stress as well as CaMKII and PKA inhibition 
ameliorates excessive intracellular Ca2+ responses to osmotic shock and hypersensitivity of EC-
coupling in mdx myocytes isolated from 3-4 month old mice (A and B) and reduces SR Ca2+ 
leak in cells from mature 12-15 month old mdx mice (C). In the experiments with osmotic shock 
(A), individual intracellular Ca2+ responses were determined as mean values of fluorescence 
recorded within the cell during 60 s after the shock, then averaged within each experimental 
group (e.g. each pharmacological intervention applied) and normalized to the averaged 
response under control conditions (no drug applied). In the EC-coupling gain experiments (B), 
averaged data within each experimental group were normalized to the values obtained in control 
(no drug applied) conditions. (C) Typical intracellular Ca2+ signals measured  during   the   “leak”  
protocol and averaged values of estimated SR Ca2+ leak under control conditions in WT and 
mdx cells and in mdx myocytes pretreated with various pharmacological agents (dashed bars). 
All values are listed in Table 1S. 
 
Figure 5 Signaling pathways involved in regulation of RyR activity in dystrophic cardiomyocytes.  
The diagram shows the main molecules involved in Ca2+ signaling and EC-coupling. Solid lines 
depict primary (oxidation and CaMKII-phosphorylation) and dashed lines depict secondary  
(nitrosation and PKA phosphorylation) mechanisms resulting in hypersensitivity of RyRs. 
Abbreviations CaCh and NaCh refer to L-type Ca2+ channel and voltage-gated Na+ channel, 
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Supplementary Materials
Methods.
Cell Isolation. C57BL10 mice (wild-type, WT) and dystrophin-deficient mdx (C57BL/10ScSn-
mdx) mice at the age of 1 (young), 3-4 (adults) and above 12-15 months old (senescent) were 
used in this study. Animals were purchased from the Jackson Laboratory. Ventricular myocytes 
from mouse heart were isolated as previously  described1. Briefly, hearts were excised, 
cannulated and retrogradely  perfused with (in mM): 140 NaCl, 5.4 KCl, 1.1 MgCl2, 1 Na2HPO4, 5 
HEPES and 10 glucose, pH was adjusted to 7.3 with NaOH at 370C. Cells were enzymatically 
dissociated with collagenase type II (Worthington) and protease (Sigma) treatment and used 
within 4-5 hours. All experiments were performed at room temperature and conformed with the 
National Institutes of Health Guide for the Care and Use of Laboratory  Animals (1996) and were 
approved by  the Institutional Animal Care and Use Committee of the New Jersey  Medical 
School of the University of Medicine and Dentistry  of New Jersey  and by the State Veterinary 
Office of Bern, Switzerland. 
Intracellular Ca2+ responses to hypo-osmotic shock. Intact cardiomyocytes were loaded with 
fluo-3 AM (5 µM, Biotium) for 30 min at room temperature followed by at least 10 min of de-
esterification. Cytosolic Ca2+ transients were recorded with fluo-3 and a laser scanning confocal 
microscope (Bio-Rad, Radiance 2000) in XY-scan mode at at the rate of 1 frame per 2 seconds. 
Fluo-3 was excited with the 488 nm line of an Argon laser and emission above 500 nm was 
collected. As a rule, 100 images were acquired: 10 images were taken in isotonic solution 
contained (in mM): 140 NaCl, 4 KCl, 1.8 CaCl2, 1.1 MgCl2, 10 glucose, 5 HEPES (further 
referred to as NT). Osmolarity  was 305 mOsm and pH was adjusted to 7.4 with NaOH. Then 20 
images were recorded in hypoosmotic solutions which contained 70 NaCl (instead of 140 NaCl) 
and consequently  reduced osmolarity  of 170 mOsm and the remaining 70 frames were recorded 
back in isotonic solution. The averaged intracellular Ca2+ responses during 60 sec after the 
osmotic shock were compared in different series of experiments.
Excitation-contraction coupling (electrophysiological recordings combined with confocal 
imaging). Membrane currents were measured using the whole cell patch-clamp procedures 
with an Axopatch 200B amplifier (Axon Instruments) controlled by custom-written data-
acquisition software developed under LabView (National Instruments). Cells were voltage 
clamped using low-resistance (1.5–3 MΩ) borosilicate glass micropipettes pulled with a Zeitz 
DMZ puller (Zeitz Instruments, Germany) and filled with pipette solution which contained  (in 
mM): 120 CsAsp, 8 NaCl, 20 tetraethylammonium (TEA)-Cl, 5.5 MgCl2, 4 KATP, 5 HEPES, and 
0.1 K5-fluo-3. pH was adjusted to 7.2 with CsOH and osmolarity  was 305 mOsm. Cells were 
held at -80 mV. After eight preconditioning pulses to 0 mV in order to equalize the SR Ca2+ load, 
a 400 ms test pulse to -25 mV was applied after an initial step to -40 mV to inactivate Na+ and T-
type Ca2+ currents. The SR loading protocol was applied in NT (with 1.8 CaCl2) with a rapid 
switch to NT (with 0.5 CaCl2) before the last preconditioning pulse. Simultaneously with Ca2+ 
currents intracellular Ca2+ transients were recorded in line-scan mode at a rate 750 lines/sec. 
The E-C coupling gain was calculated from the ratio of peak Ca2+ transients and peak Ca2+ 
currents at several tested clamp potentials and compared at different external Ca2+ 
concentrations
6XSSOHPHQWDU\0DWHULDO2WKHU
Estimation of SR Ca2+ leak. SR Ca2+ leak was estimated as described in2. Cells were paced at 
1 Hz in external control solution to obtain steady-state levels of SR Ca2+ load, and starting from 
the last five beats, [Ca2+]i was recorded in the line-scan mode (500 lines/s). After pacing, 
external solution was rapidly  switched to Na+ and Ca2+-free solution (by  substitution of Na+ with 
Li+ and addition of 0.5 mM EGTA) for 15 s to stop  Ca2+ influx and to inhibit Ca2+ removal via the 
NCX and thus, to avoid Ca2+ overload of the cells. Addition of tetracaine (1 mM, 15 s) eliminated 
RyR-mediated diastolic Ca2+ leak, leading to a rapid decrease in [Ca2+]i proportionally to the 
leak. The peak of the caffeine-induced Ca2+ transient measured after tetracaine washout (10 
mM caffeine, 2 s) was used to estimate SR load.
Measurements of cytosolic ROS production and RyR free thiol content. For the 
quantification of ROS production, cells were loaded with 20 µM of 5-(and-6)-chloromethyl-20 ,
70-dichlorodihydrofluorescein diacetate (CM-H2DCFDA, Invitrogen). CM-H2DCFDA is 
hydrolysed to DCFH in the cell, and DCFH is oxidized to form highly  fluorescent DCF in the 
presence of the appropriate oxidant (e.g. hydrogen peroxide or peroxynitrite). ROS/RNS 
generation was detected as a result of DCFH oxidation. As a rule, a series of 160 images was 
acquired at 0.5 Hz. CM-H2DCFDA was excited at 488 nm of Argon laser and emission was 
collected above 500 nm. Laser power was minimized to reduce the photoproduction of ROS. At 
the end of each experiment 10 mM H2O2 was added to determine maximum DCF fluorescence. 
The content of free thiols in RyR was determined using monobromobimane (mBB) fluorescence 
assay as described in3. Isolated cardiomyocytes were permeabilized, incubated with 1 mM of 
mBB for 1 hour in dark room and washed out 3 times to remove unbound mBB. The proteins 
were resolved in the 4-15% TGX SDS-gels (Bio-rad, CA) and transilluminated with UV light 
(excitation wavelength 360nm) by  using MultiImageTM light cabinet (Alpha innotech, CA). Total 
RyR2 was determined from Coomassie blue staining of the gels run in parallel and confirmed by 
western blotting with anti-RYR2 (Thermo Scientific, MA).The location of the RyR band on this 
gel was also reassured with Mass Spectrometry at UMDNJ core facility.
Phosphorylation and Western Blots of RyR.
Mouse ventricular tissue was collected and sonicated in the radio-immunoprecipitation assay 
(RIPA) lysis buffer (1X TBS, 1%  P-40, 0.5% sodium deoxycholate, 0.1% SDS, 0.004% sodium 
azide supplemented with phenylmethylsulfonyl fluoride PMSF, protease inhibitor cocktail and 
Calyculin A (Santa Cruz, CA)). Protein concentration in each sample was determined using an 
Eppendorf photometer with bovine serum albumin (BSA) as a standard. For immunoblotting, 40 
μg of protein lysate per sample was denatured in 4X SDS-PAGE sample loading buffer. Proteins 
were separated by  electrophoresis in to 4% (for RyR 2) and 10% (for CaMKII) respectively  SDS-
polyacrylamide gel, transferred to nitrocellulose membrane (Bio-Rad, CA) at 15V for 16-18 h at 
40C (for RyR2) and at 90V for 15 h at 40C (for CaMKII), blocked with 1% BSA in TRIS buffered 
saline and Tween (TBS: 20mM TRIS-HCl, 200mM NaCl, 0.6% tween 20, pH 7.5) for 1 hour and 
probed for proteins of interest.  Levels of RyR2, phosphorylated-RyR2, CaMKII and oxidized-
CaMKII were assessed using specific primary  antibodies: anti-RyR2 (1:500, Thermo Scientific, 
USA), anti-phosphorylated-RyR2-2808 (1:2000, Badrilla, UK), anti-phosphorylated-RyR2-2814 
(1:500, Badrilla, UK), anti-CaMKII and anti-oxidized-CaMKII (1:500, both are a gift from Dr. M. 
Anderson) and appropriate HRP-conjugated secondary  antibodies. Membranes were washed 3 
times for 15 min in TBST after primary  antibodies and secondary  antibodies incubation 
respectively.The chemiluminescence was detected and acquired on to MultiImageTM light 
cabinet (Alpha Innotech, USA). GAPDH (1:1000, Millipore, USA) was probed as a protein 
loading control.
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Data analysis and statistics. Images were pre-processed using the free software NIH ImageJ 
and further analyzed, together with electrophysiological data, in IgorPro Software 
(Wavemetrics). Results are shown as mean ± standard error of mean (SEM). All data sets 
contain results from a minimum of three mice (n on the bars indicates the number of cells). 
Statistical significance was evaluated by  Student’s t-test. A P-value of <0.05 was considered 
significant. On the graphs the significance is indicated by *.
1. Wolska BM, Solaro RJ. Method for isolation of adult mouse cardiac myocytes for studies of 
contraction and microfluorimetry. Am J Physiol 1996;271:H1250–1255. 
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Table I. Pharmacology of Ca2+ signaling in mdx cardiomyocytes.
Ca2+ responses to osmotic shock, F/F0
Inhibitor Young  
(control)
Young  
(+inhibitor)
Adult 
(control)
Adult  
(+inhibitor)
MPG 1.67 ± 0.13 (21) 1.36 ± 0.10 (17) 1.93 ± 0.18 (10) 1.33 ± 0.22 (9)
Apocynin 2.01 ± 0.18 (18) 1.50 ± 0.11 (22) 1.66 ± 0.13 (12) 1.28 ± 0.13 (13)
DPI 1.74 ± 0.12 (20) 1.21 ± 0.08 (13) 2.01 ± 0.15 (18) 1.43 ± 0.16 (9)
AIP 2.03 ± 0.15 (24) 1.38 ± 0.09 (24) 2.02 ± 0.15 (11) 1.30 ± 0.11 (11)
KN-93 1.65 ± 0.22 (13) 1.11 ± 0.04 (10)
PKI 1.76 ± 0.09 (27) 1.56 ± 0.13 (24) 1.79 ± 0.17 (21) 1.16 ± 0.08 (13)
H89 1.56 ± 0.23 (16) 1.10 ± 0.15 (24)
KT-5720 1.60 ± 0.31 (11) 1.44 ± 0.05 (10)
SMLT 1.76 ± 0.16 (15) 1.69 ± 0.13 (19) 2.10 ± 0.19 (14) 1.48 ± 0.15 (14)
1400W 1.92 ± 0.14 (24) 1.70 ± 0.12 (27) 2.08 ± 0.15 (17) 1.45 ± 0.15 (13)
EC-coupling gain @-25 mV @0.5 Ca2+, (ΔF/F0)/(A/F) 
Inhibitor Young  
(control)
Young  
(+inhibitor)
Adult  
(control)
Adult 
(+Inhibitor)
MPG
0.81 ± 0.09 (8)
0.48 ± 0.05 (8)
1.38 ± 0.27 (8)
1.39 ± 0.24 (7)
AIP 0.63 ± 0.08 (6) 0.68 ± 0.07 (6)
PKI 0.87 ± 0.11 (5) 0.73 ± 0.17 (7)
SMLT 1.02 ± 0.22 (6) 0.93 ± 0.14 (6)
1400W 0.97 ± 0.22 (6) 0.99 ± 0.16 (5)
PTIO# 0.75 ± 0.11 (8)
SR Ca2+ Leak, %
Inhibitor  Senescent  
(control)
Senescent 
(+Inhibitor)
MPG
7.18 ± 0.54 (17)
5.66 ± 0.25 (8)
AIP 4.99 ± 0.39 (8)
PKI 5.49 ± 0.72 (7)
SMLT 4.89 ± 0.35 (9)
1400W 5.09 ± 0.32 (11)
#NO scavenger PTIO (2-Phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide, 0.1 mM) was 
used to confirm results with NOS inhibitors.
Table II. Gradual deterioration of Ca
2+ signaling in m
dx cardiom
yocytes.
Young 
Young 
Adult 
Adult 
Senescent 
Senescent 
W
T 
m
dx
W
T 
m
dx
W
T 
m
dx
Ca
2+ responses to osm
otic shock, F/F
0
Ca
2+ responses to osm
otic shock, F/F
0
Ca
2+ responses to osm
otic shock, F/F
0
Ca
2+ responses to osm
otic shock, F/F
0
Ca
2+ responses to osm
otic shock, F/F
0
Ca
2+ responses to osm
otic shock, F/F
0
1.07 ± 0.01 (n=24)
1.74 ± 0.16 (n=18)
1.12 ± 0.02 (n=8)
1.88 ± 0.15 (n=18)
1.20 ± 0.01 (n=17)
1.80 ± 0.20 (n=16)   
EC-coupling gain @
-25 m
V @
0.5 Ca
2+, (ΔF/F
0 )/(A/F) 
EC-coupling gain @
-25 m
V @
0.5 Ca
2+, (ΔF/F
0 )/(A/F) 
EC-coupling gain @
-25 m
V @
0.5 Ca
2+, (ΔF/F
0 )/(A/F) 
EC-coupling gain @
-25 m
V @
0.5 Ca
2+, (ΔF/F
0 )/(A/F) 
EC-coupling gain @
-25 m
V @
0.5 Ca
2+, (ΔF/F
0 )/(A/F) 
EC-coupling gain @
-25 m
V @
0.5 Ca
2+, (ΔF/F
0 )/(A/F) 
0.45 ± 0.05 (n=5)
0.73 ± 0.05 (n=7)
0.60 ± 0.04 (n=7)
1.35 ± 0.27 (n=9)
0.55 ± 0.03 (n=6)
0.75 ± 0.08 (n=10)
SR Ca
2+ Leak, %
SR Ca
2+ Leak, %
SR Ca
2+ Leak, %
SR Ca
2+ Leak, %
SR Ca
2+ Leak, %
SR Ca
2+ Leak, %
4.61 ± 0.25 (n=24)
5.50 ± 0.32 (n=18)
4.63 ± 0.27 (n=8)
6.56 ± 0.45 (n=18)
4.25 ± 0.26 (n=17)
7.18 ± 0.54 (n=16)
SR Ca
2+ Load, F/F
0
SR Ca
2+ Load, F/F
0
SR Ca
2+ Load, F/F
0
SR Ca
2+ Load, F/F
0
SR Ca
2+ Load, F/F
0
SR Ca
2+ Load, F/F
0
3.64 ± 0.16 (n=24)
4.32 ± 0.21 (n=18)
3.91 ± 0.39 (n=8)
3.32 ± 0.15 (n=18)
4.87 ± 0.21 (n=17)
3.06 ± 0.10 (n=16)
